To many new mothers, breastfeeding is a difficult experience. As a result, many mothers do not breastfeed through the first year of life as recommended by the American Academy of Pediatrics.
To many new mothers, breastfeeding is a difficult experience. As a result, many mothers do not breastfeed through the first year of life as recommended by the American Academy of Pediatrics.
To help combat this problem, Avent America developed the ISIS iQ DUO Twin Electronic Breast Pump, unveiled today at the AAP National Conference and Exhibition in Washington, D.C. The product features an exclusive double electric breast pump with a Let-down Massage Cushion that works with a woman's natural body response to produce a fast, natural milk flow. It also features an electronic memory that "learns" and adapts with the user, making it easier for the mother to pump, and double or single electric pumping. It can be used as a manual breast pump as well.
In a clinical trial evaluating the safety and effectiveness of the ISIS iQ DUO, 93% of lactating women reported that the product was comfortable, and 89% of the women said it was easy to use. Forty-eight lactating women participated in the nonrandomized, prospective, observational study.
The product features a quiet motor to allow the mother to pump more discreetly; the ability to double pump, which studies show results in higher milk yield than sequential pumping; and soft, petal-shaped massagers that flex, intended to stimulate the areola and enhance milk flow. The pump can be set to match a baby's own suckling pattern and can be changed at each session. A closed diaphragm system prevents milk from backing up into the pump tubing, preventing contamination. The product includes an insulated tote for "on-the-go" pumping and storing.
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.